IRIS Institutional Research Information System - OPENBS Open Archive UniBS

CATTANEO, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.725
EU - Europa 2.228
AS - Asia 1.083
Continente sconosciuto - Info sul continente non disponibili 10
SA - Sud America 8
AF - Africa 6
OC - Oceania 6
Totale 7.066
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.710
CN - Cina 806
UA - Ucraina 771
DE - Germania 490
IT - Italia 356
HK - Hong Kong 214
FI - Finlandia 150
FR - Francia 127
GB - Regno Unito 114
IE - Irlanda 109
RU - Federazione Russa 54
SE - Svezia 21
IN - India 20
BE - Belgio 15
CA - Canada 14
SG - Singapore 13
TR - Turchia 12
EU - Europa 10
AU - Australia 6
BR - Brasile 4
JP - Giappone 4
PL - Polonia 4
ID - Indonesia 3
IR - Iran 3
MU - Mauritius 3
CL - Cile 2
ES - Italia 2
LT - Lituania 2
NL - Olanda 2
RO - Romania 2
AL - Albania 1
AM - Armenia 1
AT - Austria 1
BD - Bangladesh 1
BG - Bulgaria 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CO - Colombia 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
HU - Ungheria 1
IQ - Iraq 1
IS - Islanda 1
JM - Giamaica 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MA - Marocco 1
RS - Serbia 1
SA - Arabia Saudita 1
TH - Thailandia 1
VE - Venezuela 1
VN - Vietnam 1
Totale 7.066
Salva come PNG Salva come JPEG
Città #
Jacksonville 536
Fairfield 460
Woodbridge 431
Houston 314
Ann Arbor 255
Cambridge 215
Hong Kong 214
Princeton 214
Ashburn 201
Wilmington 200
Nanjing 199
Seattle 174
Chandler 143
Beijing 134
Dublin 109
New York 78
Nanchang 72
Hebei 57
Des Moines 51
Helsinki 50
Milan 47
Shenyang 43
Changsha 41
San Diego 36
Kunming 33
Jiaxing 32
Tianjin 32
Lancaster 31
Jinan 27
Shanghai 22
Hangzhou 16
Brussels 15
Nürnberg 15
Verona 15
Brescia 13
Toronto 13
Zhengzhou 13
Haikou 12
San Francisco 12
San Mateo 12
Lanzhou 11
Kocaeli 10
Monmouth Junction 10
Ningbo 10
Augusta 9
Dearborn 9
Rome 9
Taiyuan 8
Taizhou 8
Trieste 8
London 7
Lucera 7
Norwalk 7
Siena 7
Fuzhou 6
Guangzhou 6
Massa 6
Boardman 5
Changchun 5
Hanover 5
Washington 5
Leawood 4
Radomsko 4
Redwood City 4
Rovato 4
Ardabil 3
Bagnara di Romagna 3
Cagliari 3
Canberra 3
Desenzano del Garda 3
Los Angeles 3
Melbourne 3
Orange 3
Pisa 3
Solarussa 3
Strasbourg 3
Bergamo 2
Breia 2
Chiswick 2
Como 2
Crema 2
Dallas 2
Florence 2
Genoa 2
Genova 2
Greenwich 2
Modena 2
Noventa Vicentina 2
Ortona 2
Redmond 2
Reggio Calabria 2
Reggio Nell'emilia 2
Seveso 2
Tokyo 2
Torino 2
Udine 2
Vilnius 2
Abidjan 1
Arbil 1
Bacoli 1
Totale 4.839
Salva come PNG Salva come JPEG
Nome #
SINDROME DA ANTICORPI ANTIFOSFOLIPIDI E LESIONI PUNTIFORMI DELLA SOSTANZA BIANCA ALLA RISONANZA MAGNETICA. QUAL E' IL LORO SIGNIFICATO? VALUTAZIONE DI 169 PAZIENTI CON MANIFESTAZIONI NEUROLOGICHE 159
Anti-argonaute2 (Ago2/Su) and -Ro antibodies identified by immunoprecipitation in primary anti-phospholipid syndrome (PAPS). 116
In vitro cell death of activated lymphocytes in Omenn's syndrome 111
Desensibilizzazione orale alla rifampicina: descrizione di un nuovo protocollo. 108
Antiphospholipid antibody profile: implications for the evaluation and management of patients. 104
CD3-CD4+ cells with a Th2-like pattern of cytokine production in the peripheral blood of a patient with cutaneous T cell lymphoma. 103
Discordance for systemic lupus erythematosus and hyper IgE syndrome in a pair of monozygotic twins 103
Treatment of lupus skin involvement with quinacrine and hydroxychloroquine. 102
Studio con TC ad alta risoluzione (HRCT) dell’interstizio polmonare in alcune malattie autoimmunitarie sistemiche. 101
Anti-Th/To are common antinucleolar autoantibodies in Italian patients with scleroderma. 101
Idiopathic eosinophilic pneumonia and pregnancy: report of a case. 100
Circulating immune complexes in human acute leukaemia. 94
Antiphospholipid antibody: laboratory, pathogenesis and clinical manifestations 92
Inhibitory effect of IgM rheumatoid factor on immune complex solubilization capacity and inhibition of immune precipitation. 92
Antiperinuclear factor in psoriatic arthropathy 90
[Neonatal lupus: clinical features and risk of congenital cardiac heart block in newborns from mothers with anti Ro/SSA antibodies] 90
Treatment with etanercept in six patients with chronic hepatitis C infection and systemic autoimmune diseases. 88
Upregulation of myxovirus-resistance protein A: a possible marker of type I interferon induction in systemic sclerosis. 88
Immune reconstitution after bone marrow transplantation for combined immunodeficiencies: down modulation of Bcl-2 and high expression of CD95/Fas account for increased susceptibility to spontaneous and activation-induced lymphocyte cell-death 86
Electrocardiographic abnormalities in infants born from mothers with autoimmune diseases: a multicentre prospective study. 86
Nonorgan specific autoantibodies and heart damage. 86
Expression of CD28 on CD8+ and CD4+ Lymphocytes During HIV Infection 86
Systemic sclerosis therapy with iloprost: a prospective observational study of 30 patients treated for a median of 3 years. 83
Antiphospholipid antibodies and malignancies 83
IL COMPLEMENTO NELLA GRAVIDANZA DI DONNE AFFETTE DA SINDROME DA ANTICORPI ANTIFOSFOLIPIDI PRIMARIA 83
Role of anti-prothrombin in antiphospholipid syndrome. 82
I polimorfismi della metilentetraidrofolatoreduttasi (MTHFR) nel trattamento con methotrexate di pazienti con artrite reumatoide. Revisione della letteratura ed esperienza personale. 81
Oesophageal manometry in early and definite systemic sclerosis. 80
Prevalence and pattern of cognitive impairment in systemic lupus erythematosus patients with and without overt neuropsychiatric manifestations. 79
Anti beta2-glycoprotein I antibodies: clinical significance. 78
Health-related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: correlations with indexes of disease activity and severity, disability, and depressive symptoms. 77
Prevalence and clinical associations of anti-Ku antibodies in systemic autoimmune diseases. 77
Vasculite orticarioide: valutazione clinica, laboratoristica e terapeutica di 17 pazienti. 76
The immune development in a child born to a cyclosporin A-treated woman with systemic lupus erythematosus/polymyositis 76
Esposizione a latice nelle aziende sanitarie: esperienze pratiche 76
Systemic lupus erythematosus and pregnancy: a prospective study. 75
Clinical and serological features of 35 patients with anti-Ki autoantibodies. 75
Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of Low-dose versus high-dose intravenous cyclophosphamide. 74
Deforming arthropathy of the hands in Systemic Lupus Erythematosus is associated with antibodies to SS-A/Ro and to SS-B/La. 72
LUPUS ERITEMATOSO SISTEMICO AD ESORDIO TARDIVO: CARATTERISTICHE CLINICHE ED IMMUNOLOGICHE 72
Chilblain Lupus Erythematosus (CL) è associato ad anticorpi anti SSA/Ro 71
Antinuclear antibodies in psoriatic arthritis and its subgroups 69
More on anticardiolipin and anti-beta2 glycoprotein I in systemic sclerosis. 69
EVALUATION OF NEUROLOGICAL MANIFESTATIONS IN 180 PATIENTS (PTS) WITH PRIMARY ANTIPHOSPHOLIPID SYNDROME (PAPS) 69
The anti-beta-2 glycoprotein I activity in human anti-phospholipid syndrome sera is due to monoreactive low-affinity autoantibodies directed to epitopes located on native beta2-glycoprotein I and preserved during species' evolution. 68
RELATIONSHIP BETWEEN SLE SUSCEPTIBILITY GENES AND CLINICAL MANIFESTATIONS IN A COHORT OF PATIENTS WITH PRIMARY ANTIPHOSPHOLIPID SYNDROME 68
Anti-Ro/SSA autoantibodies over time in mothers of children with congenital complete heart block. 67
Prevenzione delle reazioni allergiche in pazienti sensibilizzati a latice 66
Defective expression of HLA class I and CD1a molecules in boy with Marfan-like phenotype and deep skin ulcers 66
Proliferazioni di cloni di tipo Th2 con fenotipo CD3- CD4+. Studio di 2 casi. 64
Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial. 64
Pregnancy in systemic sclerosis: a prospective study 63
Anti-TNF-alpha treatment in rheumatoid arthritis with anti-Ro/SSA antibodies. Analysis of 17 cases among a cohort of 322 treated patients 62
Esophageal Dysfunction in Patients with Definite and Early Systemic Sclerosis 62
SINDROME DA ANTICORPI ANTIFOSFOLIPIDI PRIMARIA: FOCUS SULLE MANIFESTAZIONI NEUROLOGICHE 62
AUMENTO DELLA PROTEINA C-REATTIVA, ANTICORPI ANTI-CCP E FATTORE REUMATOIDE NELL'ARTRITE LUPICA 61
Antiphospholipid and anti beta 2 glycoprotein I antibodies in patients with obstetrical complications 60
Methylenetetrahydrofolate reductase polymorphisms and methotrexate: no association with response to therapy nor with drug-related adverse events in an Italian population of rheumatic patients. 60
NEUROLOGICAL MANIFESTATIONS IN 169 PATIENTS WITH PAPS: WHICH SIGNIFICANCE FOR SMALL HYPERINTENSE WHITE MATTER LESIONS AT MAGNETIC RESONANCE IMAGING? 59
IL "PROFILO" DEGLI ANTICORPI ANTIFOSFOLIPIDI NELLA SINDROME PRIMARIA COME FATTORE DI RISCHIO PER EVENTI CLINICI: STUDIO DI 175 PAZIENTI 59
IL METHOTREXATE (MTX) E I GENOTIPI DELLA METILENTETRAIDROFOLATOREDUTTASI (MTHFR) NEL TRATTAMENTO DI PAZIENTI ITALIANI CON MALATTIE REUMATICHE 58
MANIFESTAZIONI NEUROLOGICHE IN 180 PAZIENTI CON SINDROME DA ANTICORPI ANTIFOSFOLIPIDI PRIMARIA. RUOLO DEI FATTORI DI RISCHIO CARDIOVASCOLARI 58
Chillblain lupus erythematosus is associated with antibodies to SSA/Ro 57
SINDROME DA ANTICORPI ANTIFOSFOLIPIDI PRIMARIA E LUPUS ERITEMATOSO SISTEMICO: DIFFERENZE E SOMIGLIANZE GENETIHE 56
Anticorpi antinucleo e artrite psoriasica 55
The neonatal lupus erythematosus associated with isolated LA(SSB) antibodies. 55
Anti-Ku antibodies in connective tissue disease: clinical and serologic evaluation of 14 patients. 54
Intravenous immunoglobulin in pregnancy: a chance for patients with an autoimmune disease. 54
ANTICORPI ANTIFOSFOLIPIDI E NEOPLASIE (aPL E NEOPLASIE) 54
PREGNANCY OUTCOMES IN WOMEN EXPOSED TO BIOLOGIC TREATMENT AND AFFECTED BY CHRONIC ARTHRITIS 54
Discordance for Systemic LupusErythematosus and Hyper IgE Syndrome in a pair of monozygous twins 53
Antinuclear antibodies and psoriatic arthritis 53
Five-year follow-up of 165 Italian patients with undifferentiated connective tissue diseases 52
CONNETTIVITE INDIFFERENZIATA (UCTD) DI RECENTE DIAGNOSI: PROFILO CLINICO ED IMMUNOLOGICO 52
Chilblain Lupus Erythematosus (CL) is associated with antibodies SSA/Ro 51
ANTI-RNA POLYMERASE III ANTIBODIES AS A RISK MARKER FOR EARLY DEVELOPMENT OF GASTRIC ANTRAL VASCULAR ECTASIA IN SYSTEMIC SCLEROSIS 50
ANTICORPI ANTI-SU NELLA SINDROME DA ANTICORPI ANTI-FOSFOLIPIDI PRIMARIA (PAPS) 50
Lymphadenopathic and oropharyngeal Kaposi's sarcoma in a drug addict with acquired immunodeficiency syndrome. Immunological abnormalities in peripheral blood and lymphoid tissue 50
Antiperinuclear factor (APF) in patients with psoriasic arthtritis 49
Oesophageal dysfunction in patients with definite and early systemic sclerosis 49
[TNF-alpha inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunologic effects] 49
Anti-TNFalpha treatment in patients with rheumatoid arthritis and anti-Ro/SSA antibodies. 48
Decreased number of peripheral blood CD4 + CD29+ lymphocytes and increased in vitro spontaneous production of anti-DNA antibodies in patients with active systemic lupus erythematosus. 48
Chronic urticaria induced by eradication therapy of Helicobacter pilori: a case report. 47
Induction of experimental SLE in naive mice by immunization with human polyclonal anti-DNA antibody carrying the 16/6 idiotype. 47
Anti-Ku antibodies in connective tissue diseases: clinical and serological evaluation of 14 patients 47
Undifferentiated connective tissue disease with antibodies to Ro/SSA: clinical features and follow-up of 148 patients 47
Esofagopatia sclerodermia in pazienti con sclerosi sistemica (SSC) “precoce” secondo Le Roy-Mesdger: confronto con altri subset di malattia. Studio clinico-manometrico di 181 pazienti 46
L'orticaria. 46
Esophageal manometry in patients with definitive and early systemic sclerosis 46
Isotype switching and titer variation of anti-Ro/SSA antibodies over time in 100 patients with undifferentiated connective tissue disease (UCTD). 45
Antiphospholipid antibodies and intestinal pathology 43
Lupus neonatale: manifestazioni cliniche e rischio di blocco cardiaco congenito in neonati da madri con anticorpi anti-Ro/SSA. 42
Anti-Ro/SSA antibodies in rheumatoid arthritis: clinical and immunologic associations. 42
Pretransplant antitumor conditioning (fTBI dose) correlates with bone marrow histology at day 0 in leukemic patients. 42
TERAPIE BIOLOGICHE E GRAVIDANZA: RISULTATI DI UNO STUDIO MULTICENTRICO ITALIANO 42
Lessons from the "Euro-Lupus Cohort". 42
[A high-resolution computed tomographic study of the pulmonary interstitium in systemic autoimmune diseases] Studio con tomografia computerizzata con alta risoluzione dell’interstizio polmonare in alcune malattie autoimmunitarie sistemiche. 41
LA RIDUZIONE DEL NUMERO ASSOLUTO DELLE CELLULE T CD8+CD28- CIRCOLANTI ENTRO 6 MESI DI TERAPIA CON ABATACEPT COME FATTORE PREDDITIVO DI BUONA RISPOSTA CLINICA A 1 ANNO 41
Anti-TNFalpha agents in elderly patients with rheumatoid arthritis: a study of a group of 105 over sixty five years old patients 38
Totale 6.827
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.523
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.523
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019310 0 0 0 0 0 0 0 0 0 0 153 157
2019/20201.960 376 54 56 221 81 185 121 209 103 325 94 135
2020/20211.211 17 154 21 141 36 139 46 154 239 78 167 19
2021/2022771 30 155 14 56 12 27 23 56 40 87 70 201
2022/2023578 114 5 5 20 58 174 3 54 96 3 16 30
2023/2024524 53 19 41 31 13 102 21 23 218 3 0 0
Totale 7.133